Interestingly, although the CXCR4 antagonist alone did not significantly affect bacterial load or mortality during the acute phase of infection compared to the vehicle control, we observed a trend toward improved overall survival when animals were monitored up to day 14 post-infection. This evidence concerns the gene CXCR4 and infection.